WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.
Related Posts
Após pressão dos EUA, decisão sobre plano para taxar navios poluentes é adiada; Brasil apoia proposta
Governo Trump havia ameaçado restrições de visto e sanções aos países que votassem a favor do plano, cuja decisão foi…
US says Hamas planning attack against Gaza civilians, armed group slams ‘misleading narrative’
Hamas on Sunday rejected a US State Department warning that the Palestinian armed group was planning an attack against civilians in…
Doctors try ‘poo pills’ to flush out dangerous superbugs
Can a dose of good bacteria clear superbugs from their hiding place in the bowels?